Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garraway

Showing results (441-450 of 549) with videos related to

Pageof 55
Sort By:
Cancer Discovery|March 15, 2014
Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanibNikhil Wagle, Brian C Grabiner, Eliezer M Van Allen, et al.
Cancer Cell|December 10, 2014
Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemiaDan A Landau, Kendell Clement, Michael J Ziller, et al.
Nucleic Acids Research|June 27, 2024
ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancerChen Qian, Qian Yang, Mirja Rotinen, et al.
Cell|July 29, 2017
Defining a Cancer Dependency MapAviad Tsherniak, Francisca Vazquez, Phil G Montgomery, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2015
Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanismsDouglas B Johnson, Alexander M Menzies, Lisa Zimmer, et al.
Theranostics|June 28, 2019
A Circulating Tumor Cell-RNA Assay for Assessment of Androgen Receptor Signaling Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate CancerYu Jen Jan, Junhee Yoon, Jie-Fu Chen, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Specificity of a polygenic score for aggressive prostate cancerAnna M Dornisch, George J Xu, Roshan Karunamuni, et al.
Cell|June 19, 2007
Integrative genomic approaches identify IKBKE as a breast cancer oncogeneJesse S Boehm, Jean J Zhao, Jun Yao, et al.
Cancer Discovery|November 23, 2013
MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibitionNikhil Wagle, Eliezer M Van Allen, Daniel J Treacy, et al.
The Journal of Molecular Diagnostics : JMD|August 27, 2014
Prospective enterprise-level molecular genotyping of a cohort of cancer patientsLaura E MacConaill, Elizabeth Garcia, Priyanka Shivdasani, et al.
Pageof 55

Showing results (441-450 of 549) with videos related to

Sort By:
Pageof 55
Cancer Discovery|March 15, 2014
Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanibNikhil Wagle, Brian C Grabiner, Eliezer M Van Allen, et al.
Cancer Cell|December 10, 2014
Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemiaDan A Landau, Kendell Clement, Michael J Ziller, et al.
Nucleic Acids Research|June 27, 2024
ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancerChen Qian, Qian Yang, Mirja Rotinen, et al.
Cell|July 29, 2017
Defining a Cancer Dependency MapAviad Tsherniak, Francisca Vazquez, Phil G Montgomery, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2015
Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanismsDouglas B Johnson, Alexander M Menzies, Lisa Zimmer, et al.
Theranostics|June 28, 2019
A Circulating Tumor Cell-RNA Assay for Assessment of Androgen Receptor Signaling Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate CancerYu Jen Jan, Junhee Yoon, Jie-Fu Chen, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Specificity of a polygenic score for aggressive prostate cancerAnna M Dornisch, George J Xu, Roshan Karunamuni, et al.
Cell|June 19, 2007
Integrative genomic approaches identify IKBKE as a breast cancer oncogeneJesse S Boehm, Jean J Zhao, Jun Yao, et al.
Cancer Discovery|November 23, 2013
MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibitionNikhil Wagle, Eliezer M Van Allen, Daniel J Treacy, et al.
The Journal of Molecular Diagnostics : JMD|August 27, 2014
Prospective enterprise-level molecular genotyping of a cohort of cancer patientsLaura E MacConaill, Elizabeth Garcia, Priyanka Shivdasani, et al.
Pageof 55